Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Cleland

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Biotechnology Progress|March 13, 1998
Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccinesJ L Cleland
Journal of the American Veterinary Medical Association|May 15, 1993
Extra-label drug use--veterinary practitioner views: companion animalsJ L Cleland
Journal of the American Veterinary Medical Association|September 1, 1996
Extra-label drug use: with rights come responsibilitiesJ L Cleland
Pharmaceutical Biotechnology|January 1, 1997
Protein delivery from biodegradable microspheresJ L Cleland
Trends in Biotechnology|March 31, 1999
Single-administration vaccines: controlled-release technology to mimic repeated immunizationsJ L Cleland
Pharmaceutical Biotechnology|January 1, 1995
Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systemsJ L Cleland
Journal of Pharmaceutical Sciences|August 1, 1997
Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheresJ Yang, J L Cleland
Bio/Technology (Nature Publishing Company)|December 1, 1990
Cosolvent assisted protein refoldingJ L Cleland, D I Wang
Pharmaceutical Research|October 1, 1996
Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheresJ L Cleland, A J Jones
The Journal of Biological Chemistry|February 15, 1992
Mechanism of polyethylene glycol interaction with the molten globule folding intermediate of bovine carbonic anhydrase BJ L Cleland, T W Randolph
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Biotechnology Progress|March 13, 1998
Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccinesJ L Cleland
Journal of the American Veterinary Medical Association|May 15, 1993
Extra-label drug use--veterinary practitioner views: companion animalsJ L Cleland
Journal of the American Veterinary Medical Association|September 1, 1996
Extra-label drug use: with rights come responsibilitiesJ L Cleland
Pharmaceutical Biotechnology|January 1, 1997
Protein delivery from biodegradable microspheresJ L Cleland
Trends in Biotechnology|March 31, 1999
Single-administration vaccines: controlled-release technology to mimic repeated immunizationsJ L Cleland
Pharmaceutical Biotechnology|January 1, 1995
Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systemsJ L Cleland
Journal of Pharmaceutical Sciences|August 1, 1997
Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheresJ Yang, J L Cleland
Bio/Technology (Nature Publishing Company)|December 1, 1990
Cosolvent assisted protein refoldingJ L Cleland, D I Wang
Pharmaceutical Research|October 1, 1996
Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheresJ L Cleland, A J Jones
The Journal of Biological Chemistry|February 15, 1992
Mechanism of polyethylene glycol interaction with the molten globule folding intermediate of bovine carbonic anhydrase BJ L Cleland, T W Randolph
Pageof 6